These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 2994532

  • 1. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.
    Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC.
    Ann Intern Med; 1985 Oct; 103(4):545-7. PubMed ID: 2994532
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
    Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman RC, Ramsey RB, Spira TJ.
    Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
    [Abstract] [Full Text] [Related]

  • 5. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK, McDougal JS, Jaffe HW, Spira TJ, Kennedy MS, Jones BM, Darrow WW, Morgan M, Hubbard M.
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [Abstract] [Full Text] [Related]

  • 6. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
    Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH.
    J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
    Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC.
    Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878
    [Abstract] [Full Text] [Related]

  • 9. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.
    Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Essex M.
    Ann Intern Med; 1985 May; 102(5):623-6. PubMed ID: 2984972
    [Abstract] [Full Text] [Related]

  • 10. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS, Bettelheim P, Köller U, McDougal S, Graninger W, Luger TA, Knapp W, Lechner K.
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [Abstract] [Full Text] [Related]

  • 11. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK, Kitchen LW, Prince HE, Kasper CK, Goldstein AL, Naylor PH, Preble O, Stewart JA, Essex M.
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [Abstract] [Full Text] [Related]

  • 12. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ, Wu YT, Sinangil F, Goldsmith JC.
    AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
    [Abstract] [Full Text] [Related]

  • 13. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL, Gomperts ED, McDougal JS, Ramsey RB.
    N Engl J Med; 1985 Feb 21; 312(8):483-6. PubMed ID: 2982095
    [Abstract] [Full Text] [Related]

  • 14. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Erfle V, Hehlmann R, Heimpel H.
    Klin Wochenschr; 1986 Feb 03; 64(3):115-24. PubMed ID: 3005759
    [Abstract] [Full Text] [Related]

  • 15. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV, Lewis JH, Bracken M, Toth R, Stokes J, Steffensen DO.
    Transfusion; 1986 Feb 03; 26(3):299-301. PubMed ID: 3010516
    [Abstract] [Full Text] [Related]

  • 16. Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.
    Fultz PN, McClure HM, Swenson RB, McGrath CR, Brodie A, Getchell JP, Jensen FC, Anderson DC, Broderson JR, Francis DP.
    J Virol; 1986 Apr 03; 58(1):116-24. PubMed ID: 3005641
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R, Redfield RR, Broder S.
    J Clin Invest; 1986 Aug 03; 78(2):439-47. PubMed ID: 3016028
    [Abstract] [Full Text] [Related]

  • 18. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Mar 14; 35(10):152-5. PubMed ID: 3005822
    [Abstract] [Full Text] [Related]

  • 19. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
    Ludlam CA, Tucker J, Steel CM, Tedder RS, Cheingsong-Popov R, Weiss RA, McClelland DB, Philp I, Prescott RJ.
    Lancet; 1985 Aug 03; 2(8449):233-6. PubMed ID: 2862416
    [Abstract] [Full Text] [Related]

  • 20. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
    Eyster ME, Goedert JJ, Sarngadharan MG, Weiss SH, Gallo RC, Blattner WA.
    JAMA; 1985 Apr 19; 253(15):2219-23. PubMed ID: 2983132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.